Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000041678 | SCV000065374 | likely pathogenic | Rare genetic deafness | 2009-05-12 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000522247 | SCV000617258 | pathogenic | not provided | 2017-11-07 | criteria provided, single submitter | clinical testing | The Q3587X nonsense variant has been reported previously in association with Usher syndrome (Garcia-Garcia et al., 2011; Neuhaus et al., 2017). This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. The variant is not observed in large population cohorts (Lek et al., 2016). We interpret Q3587X as a pathogenic variant. |
Counsyl | RCV000664676 | SCV000788677 | pathogenic | Usher syndrome type 2A; Retinitis pigmentosa 39 | 2017-10-06 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000522247 | SCV001212161 | pathogenic | not provided | 2024-08-13 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Gln3587*) in the USH2A gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in USH2A are known to be pathogenic (PMID: 10729113, 10909849, 20507924, 25649381). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individuals with Usher syndrome (PMID: 22004887, 28944237). ClinVar contains an entry for this variant (Variation ID: 48357). For these reasons, this variant has been classified as Pathogenic. |
Institute of Medical Genetics and Applied Genomics, |
RCV000522247 | SCV001447855 | pathogenic | not provided | 2020-10-23 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000522247 | SCV001746896 | pathogenic | not provided | 2021-04-01 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003450740 | SCV004182177 | likely pathogenic | Retinitis pigmentosa 39 | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003450739 | SCV004182178 | likely pathogenic | Usher syndrome type 2A | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV003450740 | SCV004208361 | pathogenic | Retinitis pigmentosa 39 | 2023-08-01 | criteria provided, single submitter | clinical testing |